Published in
Elsevier, Clinical Therapeutics, 9(37), p. 2019-2027, 2015
DOI: 10.1016/j.clinthera.2015.06.014
Links
Tools
Cost–Benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-Risk Hematologic Patients: A Propensity Score-Matched Analysis
Journal article published in 2015 by
Dong-Gun Lee,
Jae-Ki Choi,
Hyo-Jin Lee,
Sung-Yeon Cho 
,
Si-Hyun Kim,
Sun-Hee Park,
Su-Mi Choi,
Jung-Hyun Choi,
Jin-Hong Yoo,
Yoo-Jin Kim,
Hee-Je Kim,
Woo-Sung Min,
Heejung Back,
Sukhyun Kang,
Eui-Kyung Lee
,
Si-Hyun Kim,
Sun-Hee Park,
Su-Mi Choi,
Jung-Hyun Choi,
Jin-Hong Yoo,
Yoo-Jin Kim,
Hee-Je Kim,
Woo-Sung Min,
Heejung Back,
Sukhyun Kang,
Eui-Kyung Lee
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 